Cybin Inc. (NEO:CYBN)
8.53
+0.11 (1.31%)
May 7, 2025, 3:59 PM EDT
Cybin Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
50
Market Cap
176.20M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | - | - | - |
Mar 31, 2023 | - | - | - |
Mar 31, 2022 | - | - | - |
Mar 31, 2021 | 864.00K | - | - |
Mar 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Green Thumb Industries | 1.64B |
dentalcorp Holdings | 1.55B |
Sienna Senior Living | 893.16M |
Trulieve Cannabis | 1.71B |
Extendicare | 1.47B |
Cronos Group | 169.23M |
WELL Health Technologies | 919.69M |
Curaleaf Holdings | 1.93B |
Cybin News
- 6 days ago - Cybin to Participate at the 28th Annual Milken Institute Global Conference - Business Wire
- 14 days ago - Cybin Announces Additional Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Phase 3 Program Evaluating CYB003 - Business Wire
- 16 days ago - Psychedelic drug developer Cybin partners with Osmind - Seeking Alpha
- 16 days ago - Cybin Partners with Osmind to Accelerate Commercial Preparation for its Clinical-Stage Psychiatry Programs - Business Wire
- 7 weeks ago - Cybin wins new Buy from Guggenheim: potential to challenge J&J’s Spravato cited - Seeking Alpha
- 3 months ago - Cybin reports Q3 results - Seeking Alpha
- 3 months ago - Cybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights - Business Wire
- 3 months ago - Cybin: Paradigm Changing Ambitions - Seeking Alpha